We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Partnership to Offer New Coagulation Testing Solutions Worldwide

By LabMedica International staff writers
Posted on 26 Apr 2015
Print article
Image: In a new collaboration, Abbott will be the exclusive distributor of Sekisui\'s new CP3000 coagulation instrument in various regions, enabling Abbott to provide coagulation testing solutions with the CP3000, a high-throughput system with a compact footprint (Image courtesy of Abbott).
Image: In a new collaboration, Abbott will be the exclusive distributor of Sekisui\'s new CP3000 coagulation instrument in various regions, enabling Abbott to provide coagulation testing solutions with the CP3000, a high-throughput system with a compact footprint (Image courtesy of Abbott).
Abbott (Abbott Park, IL, USA) and Sekisui Diagnostics LLC (Lexington, MA, USA), a sister company of Sekisui Medical (SMD; Tokyo, Japan ), have entered an agreement to offer new coagulation testing solutions for clinical labs to help better assess patient risk of excessive bleeding, developing clots, and other conditions.

Under the agreement, Abbott will be the exclusive distributor of Sekisui's new CP3000 coagulation instrument in various regions, enabling Abbott to provide its coagulation testing solutions with the CP3000, expected to become available later in 2015 in Europe, countries that recognize CE-marking, and non-regulated countries, and in 2016 in the United States. Abbott will have non-exclusive distribution rights with Sekisui in China, Hong Kong, Japan, and Macau.

CP3000 features small sample volume requirement, high-throughput, and a compact footprint. With a broad assay menu and rapid result turnaround time, CP3000 can rapidly meet workflow needs of laboratories of all sizes while providing high quality, reliable results. The system will aim to seamlessly connect to Abbott's “Accelerator a3600” lab automation platform and middleware solution.

"Abbott is committed to providing testing solutions that healthcare providers rely on for actionable information in diagnosing and treating various medical conditions," said Jaime Contreras, senior vice president, Commercial Operations, Diagnostics, Abbott, "Collaborating with Sekisui broadens our offerings within hematology, providing an important component needed to improve care for people around the world." Coagulation testing helps diagnosis blood-related disorders such as hemophilia and thrombosis, and helps clinicians assess patients prior to many medical treatments and in monitoring those who take medications that can affect clotting.

“Coagulation testing has been an important focus for Sekisui for over 20 years," said Robert Schruender, president and chief operating officer of Sekisui Diagnostics, "We are delighted that this relationship with Abbott will bring the benefits of our system, a leading product in Japan, to many customers around the world."

Related Links:

Abbott
Sekisui Diagnostics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.